In this prospective cohort study of African-American and White participants within the REGARDS cohort, higher levels of baseline circulating IL-6 was associated with higher overall and obesity-associated cancer mortality. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.